ABSTRACT A method is given for design of experiments to detect associations (linkage disequilibrium) in a random population between a marker and a quantitative trait locus (QTL), or gene, with a given strength of evidence, as defined by the Bayes factor. Using a version of the Bayes factor that can be linked to the value of an F -statistic with an existing deterministic power calculation makes it possible to rapidly evaluate a comprehensive range of scenarios, demonstrating the feasibility, or otherwise, of detecting genes of small effect. The Bayes factor is advocated for use in determining optimal strategies for selecting candidate genes for further testing or applications. The prospects for fine-scale mapping of QTL are reevaluated in this framework. We show that large sample sizes are needed to detect small-effect genes with a respectablesized Bayes factor, and to have good power to detect a QTL allele at low frequency it is necessary to have a marker with similar allele frequency near the gene.
T HE advent of dense maps of single-nucleotide polydesign. Then we discuss measures of statistical evidence or criteria for "detecting" associations. We argue that morphisms (SNPs) covering the genome with 300,000 or more markers offers new opportunities to find and there are problems with commonly used P-values as a measure of evidence and advocate the Bayes factor (see, identify genes, by testing for population-level associations e.g., Spiegelhalter and Smith 1982) as a replacement between the SNP and disease or other trait of interest.
measure. Further information including relationships Associations occur because of linkage disequilibrium between Bayes factors, posterior probabilities, type I error between the marker and trait. "Linkage disequilibrium rates, P-values, power, and false discovery rates as evi-(LD) mapping" aims to detect and locate genes relative dence for gene effects is given in appendix b. Then, we to a map of existing genetic markers. Location informareview and correct the deterministic power calculation tion is obtained because the distance between the gene from Luo (1998) (with technical details in appendix and a marker on a chromosome is one factor influenca) and the classical approach to power of experiments ing the closeness of association between the gene and and then introduce a generic Bayes factor (Spiegelhalmarker. In a population, recombinations affecting the ter and Smith 1982) for comparing linear models, in association between a gene and marker may occur over the absence of prior information. This is linked to the many generations. This potentially gives a much finer classical power calculation, to give designs with a given resolution than pedigrees used for quantitative trait loci probability to detect an effect with a given Bayes factor. (QTL) mapping. Finer resolution comes at a cost, howResults are presented for sample sizes ranging from ever. More genotyping is needed per individual and as 600 to 4800 and Bayes factors ranging from 1 ⁄20 to 20 and we shall show, larger sample sizes are needed to take for a range of QTL and marker allele frequencies rangadvantage of a finer level of resolution. In this article we ing from 0.01 to 0.5 for sample sizes ranging from 600 to develop experimental design techniques necessary to 38,400 with a Bayes factor of 20. Applications to genome find the sample size needed to reliably detect a given scans and testing large sets of candidate genes are dislevel of linkage disequilibrium between a biallelic QTL cussed, with results for posterior odds ranging from 1 ⁄20 and marker.
to 20 (Bayes factors ranging from 250 to 1,000,000). The This article is structured as follows. First we review discussion section gives wider applications and impliprospects for LD mapping with SNP markers, possible cations of the method for strategies for gene discovery. strategies, and results to date, including problems with Kruglyak (1999) , reviewing prospects for wholereliability of detected QTL, illustrating the need for a genome linkage disequilibrium mapping, suggests that sound measure of statistical evidence and experimental the useful range of linkage disequilibrium in the human population is around 3 kb, corresponding to a map with 500,000 SNP markers. The high density of SNP markers, 1 to locate SNPs near the genes and hence to sequence approach, with data from association studies, but note that the method could be applied to haplotype data regions containing genes. Results in the literature on the range of usable linkage disequilibrium are variable.
where two classes of haplotypes are considered. The large number of possible SNPs and the even larger Dunning et al. (2000) report a similarly low range of disequilibrium in humans, while Taillon-Miller et al. number of possible haplotype combinations make it essential to have soundly based statistical evidence for (2000; reviewed in Boehnke 2000) report strong LD at distances as high as 1 Mb. At the other extreme, LD putative associations. This may not be the case in general in published literature, i.e., Altshuler et al. (2000) , disextending over a wide range has been reported in domesticated species by, e.g., Dunner et al. (1997) and cussed in Gura (2001 , p. 594): Farnir et al. (2000 for cattle and by McRae et al. (2002) . Figure 4) show the Centre are interested in economic traits for forest trees, distribution of ‫062ف‬ reported P-values from association such as growth rate or wood density. Results from QTL studies in two journals and note that there is no evidence mapping studies (Wilcox et al. 1997; Kumar et al. 2000;  of departure from the uniform distribution (i.e., no Ball 2001) suggest that these traits may be influenced evidence of any real effect): by a number of smaller-effect genes.
Roses ( a subset of SNP markers associated with the responses to medicine(s) of interest and then using the values of These results point to lack of reliability of published these SNPs for an individual to predict the individual's results. Clearly, the statistical criteria used have not led response.
to reliability of "detected" SNPs in these examples. ExpeThere are two general strategies for detecting associarience, and the results below, suggest this problem is tions: testing for random associations in a population likely to be widespread. The objective of this article is or using family-based tests such as the transmission disto design experiments for testing associations with the equilibrium test (Allison 1997; Boehnke and Langerequired quantifiably stronger statistical evidence. feld 1998; Spielman and Ewens 1998; Long and Lang- Terwilliger and Weiss (1998) suggest as a cause of ley 1999). See Nielsen and Zaykin (2001) for a review.
the problem that the simple model underlying the assoThe random population association test has the disadciation tests does not reflect the genetic complexity, citvantage of being confounded with allele frequency difing allelic and nonallelic heterogeneity, genetic-by-enviferences in subpopulations, if there is any population ronment interactions, intragene interactions (epistasis), substructure, while the transmission disequilibrium test etc. We suggest that, while this may be true, resulting requires availability of many small families.
in complex statistical interactions, there is no hope of Note that where there may be population substrucdetecting the interactions if one cannot first detect and ture we recommend the method of Pritchard et al.
isolate the main effects, which would imply a model (2000a,b) for estimating and allowing for population similar to that underlying association tests. We suggest substructure. This requires additional markers and may the problem is not with the model but with the basic reduce power due to the additional number of paramestatistical experimental design (insufficient power) and ters to be estimated.
statistical criteria for detection (P-values) . With either of these strategies there are currently two common approaches: testing for single-marker associa-METHODS tions or testing haplotypes on the basis of a combination of marker values associated with the disease or quantiEvidence for a real effect-P-value and posterior probability for H 1 : We argue that the P-value, the commonly tative trait. In this article, we consider the single-marker used measure of statistical significance, is not a sound to be sure there really was good evidence for an effect in the first place and then obtain good evidence for an measure of evidence for a real effect and that the solution of the problems is to adopt a sound framework for interaction. This article quantifies the level of replication required statistical inference, based on probability theory, first given in Bayes (1763).
for association studies, for reliably detecting linkage equilibrium between a DNA marker (or gene) and a The P-value is the probability of observing a test statistic more extreme than the observed test statistic under trait, with particular interest in detecting small-effect genes. To do this we apply the Bayesian approach to repeated sampling assuming the null hypothesis of no effect holds. The problem is that there is no valid interassessing evidence, using the Bayes factor. Sample sizes needed to detect effects of various sizes with a given pretation of P-values as evidence for a real effect independent of sample size and test setup. One reason is that strength of evidence as defined by the Bayes factor, with a given probability (power), for a given level of linkage the P-value is a probability under H 0 ; the corresponding probability under H 1 , which is not controlled by the disequilibrium between a biallelic marker and a biallelic quantitative trait locus, are determined. P-value alone, may also be comparably small (appendix b, Equations B10 and B11), in which case the evidence for
We make use of an existing deterministic power calculation (Luo 1998) for the power of detecting linkage H 1 will be weak. For a given sample size and test setup, smaller and smaller P-values correspond to stronger disequilibrium between a biallelic QTL and a marker. The type I error rate (or P-value) corresponding to the and stronger evidence. However, we cannot say how small a P-value is required for a given strength of evidesired Bayes factor is determined for each set of parameter values and plugged into the deterministic power dence or even quantify strength of evidence, except by reference to Bayesian methods for specific sample sizes calculation.
Genetic model:
We assume a biallelic marker with and test setups. The larger the sample size, the smaller the P-values need to be to correspond to a given strength alleles M, m and a biallelic QTL with alleles A, a. Following Luo (1998), let q, p be the probability of A, M, reof evidence. We shall see that, for the large sample sizes needed for detecting linkage disequilibrium, reasonable spectively. In the biallelic case, linkage disequilibrium is specified by a single coefficient, D, such that the joint evidence corresponds to very small P-values (Table 3) , much smaller than those generally used, explaining the probabilities of alleles are given by unreliability of published results. For further discussion Pr Weir 1996) . It follows that the conditional probaproblem is overestimation of effects caused by selection bilities are given by bias. If effects of selected markers are real but not reliably detected, i.e., the power of detection is not high,
then reusing the same data to estimate the size of an
effect as was used to select a marker results in an upward bias in the size of effects that can be large, in percentage
The genotypic frequencies of pairwise combinations of terms. The solution is either to use an independent pop-QTL and marker genotypes are determined from these ulation to obtain unbiased estimates of effects (which is quantities ( 
applies ideally to sets of multiple markers, but can also where i, j, k index marker genotype, QTL genotype, be applied when considering only a single marker, in and observations within marker and QTL genotype, rewhich case the models averaged over correspond to the spectively. Since the QTL genotypes are unobserved, null hypothesis H 0 with no effect and the alternative the data are analyzed with a one-way analysis-of-variance hypothesis H 1 with a real effect. model, with marker genotypes as groups, i.e., Other problems: The interpretation of P-values as representing good evidence for real effects is one, although
(6) possibly not the only problem with reliability of published data. Other problems may include spurious assoThe ANOVA table for this analysis is shown in Table 2 . Classical power calculation: The classical statistical ciations arising from neglecting population structure or inadequate experimental design. Or it may be that the experimental design seeks to determine designs with a given "power" P at a given significance level ␣; i.e., the genetic effects are not "stable" across different environments or subpopulations sampled by various trials. Beprobability of obtaining a result with P-value less than ␣ is P, assuming the effect to be detected is at least a fore claiming that there is instability, however, we need 
Ϫd
Marker genotypes are MM, Mm, mm ; QTL genotypes are AA, Aa, aa.
certain size. The effect is said to be detected if this Experimental design with power to obtain a given Bayes factor: Bayes' theorem follows from the basic law of consignificance level is obtained.
The null hypothesis is "rejected" at level ␣ if the obditional probability: served value F-statistic is greater than the 1 Ϫ ␣ point Pr(A|B)Pr(B) ϭ Pr(A ʝ B) ϭ Pr(B |A)Pr(A) (10) of its distribution under the null hypothesis, or
If we have observed B the probability of A being true is Pr(A|B). Bayesian statistics applies this with B as the The probability of rejecting the null hypothesis or power is the probability that the F-statistic exceeds the data (y) and A as an unknown parameter (). Replacing A by and B by y and representing the probability funccritical value. To find this probability we need to know the actual distribution of the F-statistic under the altertions by f, , and g gives native hypothesis, which in this case means there is a
(12) biallelic QTL in linkage disequilibrium with a marker with parameters D, d, h, p, and q defined above.
It follows (by integrating both sides over ) that Under the alternative hypothesis F is distributed as
where EMS b and EMS w are the expected values of the This has the following interpretation: the prior distribumean squares between and within marker classes (cf. Tation () represents our knowledge of the unknown ble 2; Johnson and Kotz 1970, p. 189; Luo 1998, Equabefore observing the data y, and the posterior distribution tion 6.2). The power is given by g(|y) represents our knowledge of the unknown after observing the data. In other words has been updated
to g. f(y) is the probability of the data. where F 1 , 2 (␦) is a random variable with the F-distribuNow suppose we have two hypotheses (or models), H 0 (e.g., the hypothesis of no linkage disequilibrium) and tion with 1 , 2 d.f., and noncentrality parameter ␦.
To determine ␦ and complete the calculation, it re-H 1 (e.g., the hypothesis of a nonzero QTL effect in linkage disequilibrium with a marker). Each hypothesis repmains to determine the expected mean squares EMS b and EMS w for the problem. Details of the calculation inresents a model with unknown parameters and probability density functions. Let i be the parameters under H i cluding derivation of modified values for 23 , EMS b , and EMS w are given in appendix a.
( i ϭ 0, 1) and let
, and f i (y) be Table 3 ). "true" model.
Note that the reader may find some similarity between The Bayes factor, B, measures the strength of evidence the likelihood ratio and the Bayes factor: in fact, the in the data in support of one hypothesis (or model),
Bayes factor is the same as the likelihood ratio-if there H 1 (e.g., the hypothesis of a nonzero QTL effect in linkare no unknown parameters. However, use of the Bayes age disequilibrium with a marker), over another, H 0 factor is not the same as the use of the likelihood-ratio (e.g., the hypothesis of no linkage disequilibrium), and test (cf. the discussion). is defined as the ratio of the probability of the data Prior odds are part of prior knowledge, but do not under H 1 to the probability of the data under H 0 , i.e., affect the Bayes factor. The Bayes factor is, however, affected by the prior distribution of parameters
Pr(y |H 1 ) Pr(y |H 0 )
. (15) above], particularly the parameters being tested. In general the more prior information we have on the parameter values under H 1 , the higher the Bayes factor we will Higher Bayes factors (Ͼ1) are stronger evidence for H 1 , obtain. while lower Bayes factors (Ͻ1) are evidence for H 0 . A In a particular situation, where there is prior informaBayes factor of 1 means the data are equally likely under tion one should choose somewhat conservative prior dis-H 0 and H 1 , so there is no evidence either way. Bayes' tributions for these parameters, so the evidence for an theorem in this case can be written as effect is not exaggerated. A vague prior that puts most Pr(H 1 |y)/Pr(H 0 |y) ϭ B ϫ (H 1 )/(H 0 ), (16) prior mass on very large numbers should also not be used naively-in the limit as prior information tends to where (H i ) and Pr(H i |y) are the prior and posterior zero, the Bayes factor also tends to zero. To develop a probabilities of H i , i.e., generic method, or where there is no prior information, posterior odds ϭ Bayes factor ϫ prior odds. (17) one way to proceed is to start with priors with little or no prior information and update these priors using a The Bayes factor has a natural interpretation in terms small "training sample" (y a ; i.e., replace the priors by the of betting odds. Prior odds are the odds we would be posteriors after observing y a ) and use the rest of the prepared to bet on prior to seeing the data; posterior data to estimate the Bayes factor with the updated priors. odds are the odds we would be prepared to bet on after It can be shown that this is equivalent to defining seeing the data. Equation 17 has the interpretation that the Bayes factor is the factor by which we multiply our
prior odds after seeing the data. For example, if we had where B 0 (y) denotes the Bayes factor with data y and prior odds of 1:10 (i.e., odds against a QTL in a given the original priors and B(y) is the Bayes factor with data region) and a Bayes factor of 100 our posterior odds y and the updated priors. would be 10:1 (100 ϫ 1 ⁄10 ϭ 10). This may not sound Note that now [setting y ϭ y a in (18)] the Bayes factor impressive to readers accustomed to P-values Ͻ0.01 or is calibrated to be 1 for the small training sample. This even 0.001 but we shall see that it is not easy to obtain is reasonable because the training sample is small and evidence this strong. For example, in a t-test with a noninformative or nearly noninformative prior distribution so contains little or no evidence either way, which is the value of ␣ from the F-distribution. Then given ␣ and n we determine the power, P, from the classical power calculations. To determine the sample size n for consistent with the interpretation of B(y) ϭ 1. This is given B and P we use interpolation. the motivation for the approach of Spiegelhalter and An R package (ldDesign) containing code used for the Smith (1982) who obtain, for a one-way analysis-of-varicalculations is available on the Comprehensive R archive ance model, network (CRAN), from http://cran.r-project.org/src/ contrib/Descriptions/ldDesign.html.
where m is the number of groups, n i is the number in RESULTS each group, n is the total sample size, and F is the classical F-value. Table 3 shows the type I error rates (or P-values) corresponding to various Bayes factors. For a desired Bayes Note that our definition of B is the reciprocal of that used by Spiegelhalter and Smith, so high Bayes factors factor (e.g., B ϭ 10, which implies the data are 10 times more likely under the hypothesis of a real effect than correspond to positive evidence for H 1 .
This form of the Bayes factor is particularly conveunder the hypothesis of no effect), look up the type I error rate in the table for the sample size desired. For nient, because it links directly to the F-statistic used in existing power calculations. To detect an association example, if the sample size is 1728, we need a type I error rate of ␣ Ͻ 2.35 ϫ 10 Ϫ4 to get B ϭ 10. If the with power P to achieve a given Bayes factor B we solve for F in (19) and select a design using the existing desample sizes is 300, we need a type I error rate of ␣ Ͻ 1.42 ϫ 10 Ϫ3 to get B ϭ 10. For these sample sizes, ␣ ϭ terministic power calculation.
Note that in general the Bayes factor is sensitive to 0.05 and even ␣ ϭ 0.01 are clearly not a good option, corresponding mostly to Bayes factors Ͻ1. For examthe prior for the variable(s) being tested (here marker effects). Use of (19) does not require specification of ple, with n ϭ 864, B ϭ 1 ⁄10, we have P Ϸ 0.05-showing that a P-value of 0.05 can correspond to evidence against a prior, which is especially useful in a general experimental design context where there are no specific data an effect. Table 4 is a comparison with results for 12 sample and hence no prior. Intuitively, it seems reasonable that the above calibration is equivalent to using a nearly nonpopulations from Luo (1998). P 0.05 is the power to detect an effect with comparisonwise significance level ␣ ϭ informative prior with information comparable to that in the small training sample. This is consistent with our 0.05, as shown in Luo's (1998) Table 3 . Also shown are the equivalent Bayes factors, B, and the sample size n B 20 experience-when we have used priors with information equivalent to one data point, the resulting Bayes required to obtain a Bayes factor of 20 with power 0.9. Note that the Bayes factors for the original sample sizes factors were similar to (19).
Equation 19 applies to testing for linkage disequilibare all Ͻ1, i.e., not corresponding to positive evidence for a real effect. The sample sizes n B 20 are the sample rium (cf. the ANOVA table, Table 2 ), where m ϭ 3 is rium reaches its maximum, although this may happen for a lower D when q is lower (cf. top row, middle graph with n ϭ 4800, p ϭ 0.2). However, very low power occurs when there is a poor match between marker and QTL frequencies (e.g., p ϭ 0.01, q ϭ 0.5 or p ϭ 0.5, q ϭ 0.01).
Application recommendations: The Bayes factor gives a well-defined measure of strength of evidence, independent of the experimental design or sample size used. The optimal value to use depends on the costs of further experimentation and possible benefits. A Bayes factor of 20 or more represents good evidence for an effect; however, one needs to factor in the prior odds. An effect that is a priori unlikely needs a high Bayes factor to obtain respectable posterior odds. A more formal costbenefit analysis is possible, in the Bayesian decision theory framework; see, e.g., DeGroot (1970) and Lindley (1985) .
Use with genome scans: In a genome scan the prior odds for a gene to be in the vicinity of a particular marker, defined as the region closer to that marker than to any other, are proportional to the number of genes expected and inversely proportional to the number of markers (cf. Ball 2001). In a genome scan with many markers the prior probability would be small; therefore (1999) suggests that D ϭ 0.1 may be obtainable for the human population, at distances between QTL and marker of up to 3 kb, corresponding to a map with 6 kb sizes required to have good power to detect an effect spacing and 500,000 markers. with fairly strong evidence and are substantially (up to For example, if it is desired to localize an effect to 13 times) larger.
the nearest of 500,000 SNP markers and ‫01ف‬ genes Note that our calculations for the power, P 0.05 , to dewere expected, the prior probability per marker would tect an effect with significance level ␣ ϭ 0.05 agree with be ‫.000,05/1ف‬ To obtain respectable posterior odds of those from Luo's (1998) Table 3 and with our stochastic say 20:1 in (16), we would require a Bayes factor of simulations, except for populations 11 and 12, which 1,000,000. agree with our simulations but do not agree with the Table 5 shows sample sizes required for localizing results from Luo (1998). Luo obtained powers of 0.65, QTL in a genome scan with 500,000 SNP markers, as-0.60, which are similar to the power obtained when φ ϭ suming there are 10 QTL. A sample size of Ϸ40,000 is 0. It may be that he used φ ϭ 0 for the power calculations needed for a power of 0.9 to obtain posterior odds of for these populations.
20:1 for a QTL explaining 1% of the phenotypic vari- Figure 1 shows graphs of power vs. linkage disequilibance with D ϭ 0.1 to be within Ϯ3 kb of a given marker. rium. Graphs correspond to sample sizes n ϭ 600, 1200, Note that, in relative terms, the sample sizes to obtain 2400, 4800 and QTL heritabilities (or proportions of phethe higher Bayes factors do not increase much at the notypic variance explained) of h date" genes were being tested, at an initial screening 10, and 20. The lines, in order of increasing power, stage of experimentation, one may be content with poscorrespond to the Bayes factors in decreasing order.
terior odds of Ͻ1. In this case one would want to be sure Graphs of power vs. disequilibrium for various values the effects of interest had a high probability (power) of of marker and QTL allele frequencies are shown in being accepted, while the genes not affecting the trait Figure 2 . To facilitate comparisons across the range of have a low probability. For example, suppose 50,000 allele frequencies disequilibrium has been represented candidate genes were tested with a sample size of n ϭ as DЈ ϭ D/D max , which varies from 0 to 1, with 1 repre-4800, and we are looking for QTL explaining 1% of the senting the maximum possible linkage disequilibrium phenotypic variance (h Table 6 shows sample sizes required for selecting genes from a set of 50,000 candidate genes, assuming there other hand requiring B ϭ 20 would eliminate 80% of the genes with D Ն 0.13, which is hardly satisfactory. are 10 true genes. A sample size of Ϸ36,000 is needed for a power of 0.9 to obtain posterior odds of 20:1 for For QTL with h 2 Q ϭ 0.05, the situation is more favorable: with n ϭ 4800 and D Ն 0.1 there is a 95% power to a gene explaining 1% of the genetic variance, with D ϭ 0.1 to be within Ϯ3 kb of a given marker. As with Table detect genes with D Ն 0.1 with a Bayes factor of 20, with a rate of Ͻ1/1000 false positives. 5, the sample sizes needed to obtain the higher Bayes factors are not much higher in relative terms. The results of Table 4 show that using a threshold of needed to obtain good evidence (a Bayes factor of 20)
Prior probability per marker is assumed to be 1/50,000.
with power 0.9. power calculations can be rederived. We would expect that a transmission test of equivalent power (in the classiPrior probability per marker is assumed to be 1/5000.
cal sense) to the designs considered here would have a similar power to achieve a given Bayes factor; i.e., existing comparisons between the power of these tests and those of association studies would apply. However, this The results of Figure 1 show that good power is is yet to be confirmed. achieved with a sample size of n ϭ 2400, for a 5% QTL An alternative to considering single markers sepawith D ϭ 0.15, to detect linkage disequilibrium with a rately is to study haplotypes. For example, if one is inBayes factor of 20. However, at n ϭ 4800 and D ϭ 0.1 terested in a particular haplotype or class of haplotypes power is low even for a Bayes factor of 1. from a subset of SNPs being associated with a higher The results of Figure 2 show that power may be very level of disease, compared with all other haplotypes from low if low QTL allele frequency is not matched by a low the subset, this can be considered a biallelic marker for marker frequency. In this case the linkage disequilibwhich the methods of this article apply. If more than two rium is much lower than the maximum possible for the haplotype classes are considered the equivalent power given QTL allele frequency. This sensitivity of power to calculations would need to be derived. Use of P-values allele frequency is one reason why plots of the LD test is problematic in this situation because P-values are statistics in the neighborhood of a gene generally vary affected by considerations, such as which other haplowildly, in a nonsmooth fashion. To detect a gene, partictypes or haplotype classes are tested. The Bayesian apularly one with a low-frequency allele, it is important proach is well suited to haplotypes-the Bayes factor or not only to have a marker close to the gene but also to posterior probability does not depend on such conhave a marker with similar allele frequency. For a ransiderations. Of course if there were a very large number domly chosen marker in the vicinity of a gene it seems of combinations or partitions of haplotypes the prior that this would occur with low probability for a lowprobability for a randomly chosen haplotype would be frequency QTL allele. This further increases the numlow, and a high Bayes factor would be required. ber of markers needed for adequate genome coverage
The Bayes factor depends on the prior for the variand/or the population size needed to detect such genes.
able(s) being tested (here marker effects). We have The results of Tables 5 and 6 show that it is feasible, used a generic or "default" Bayes factor that avoids this albeit with large sample sizes of the order of 7500 and prior dependence, giving a generic result that can be 40,000, to detect and locate QTL that explain 5%, 1%, applied in the absence of further prior information. In or more of the genetic variance, respectively, with a specific situations it may be possible to do better when linkage disequilibrium of D ϭ 0.1, by testing sets of up prior information on the size of QTL effects is available. to 50,000 candidate genes or 500,000 SNP markers. For For example, the variance due to a QTL can be no more genome scans, it is possible to borrow strength from than the genetic variance of the trait, for which estimates neighboring markers, justifying higher prior probabiliare often available. However, in our experience, this ties when estimating the marginal probability for a set amount of prior information is not enough to make a of markers in a larger region (cf. Ball 2001). This canmajor difference. not be pushed too far, however: because of the short
The approach used here, of determining the power range of usable linkage disequilibrium indicated in to achieve a given Bayes factor, is a hybrid of Bayesian Kruglyak (1999), only a small number of the 500,000
and non-Bayesian (frequentist) approaches. We are studymarkers would be close enough to a given gene.
ing the sampling distribution (frequentist) of the Bayes An alternative, in view of the large sample sizes indifactor (a Bayesian measure of evidence). This is approcated for detecting small QTL with the genome scan or brute force candidate gene approaches, is a hybrid priate because we are interested in possible outcomes 
Taking expectations,
where V p is the total, or phenotypic, variance. Solving for EMS b gives
Finally, we need an expression for V p . Substituting from Equation 5 and taking variances gives
APPENDIX B: BAYES FACTORS, POSTERIOR PROBABILITIES, TYPE I ERROR RATES, P-VALUES, POWER, AND FALSE DISCOVERY RATES AS MEASURES OF EVIDENCE FOR GENE EFFECTS
To fix notation, suppose H 0 represents the null hypothesis that ϭ 0 (a so-called "precise" hypothesis), and H 1 represents the alternative hypothesis that ϶ 0, where represents one or more parameters for a genetic effect to be tested, which are zero under the assumption of no effect. There may be other parameters common to both H 0 and H 1 ; these are suppressed.
Type I error rates and P-values: The type I error rate (␣) for a test is given by
where T is a "test statistic," and T c is the ␣-critical level of the test statistic (which we also write as T ␣ ), such that H 0 is rejected if T Ն T c . Type I error rates are valid if ␣ is chosen preexperimentally. However, ␣, being chosen preexperimentally, does not make full use of the information in the data, which is not efficient. Fisher proposed reporting the P-value, which is the value of ␣ when we set T c ϭ T obs , the observed value of the test statistic:
The P-value is the smallest, i.e., most optimistic, value of ␣ under which H 0 would have been rejected. However, we cannot set ␣ ϭ p after observing the data-the P-value is not a valid type I error rate. Therefore it is problematic to make a decision on the basis of one or more P-values. Even if we had chosen ␣ preexperimentally, giving an average type I error rate under repeated sampling, we would not be able to quantify the evidence for a particular sample that may be worse than average. Bayes factors as evidence and relationships with P-values: Bayes factors have a natural interpretation as evidence from Equation 16. Higher Bayes factors correspond to stronger evidence for H 1 .
Intuitively, more extreme values of the test statistics mean that the data are more likely than those for smaller values to have come from H 1 ; i.e., smaller P-values correspond to stronger evidence. Experience confirms this: for a given problem (H 0 , H 1 , and sample size) with an intelligently defined test statistic, a plot of P-value vs. the Bayes factor shows a monotone relationship (cf. Table 3 ). This means, for example, that P-values and Bayes factors would give the same ranking of genes in order of strength of evidence but does not imply Bayes factors and P-values are equivalent; how to rank genes in order of expected benefit (considering size of gene effects as well as strength of evidence) or how many putative genes to select for further investigation becomes clear only when Bayes factors or posterior probabilities are calculated.
The relationship between Bayes factors and P-values is quantified implicitly in Equation 19 from Spiegelhalter and Smith (1982) for the one-way analysis-of-variance model, where the F-value corresponds to the P-value through the F-distribution. This relationship varies in general, depending on sample size (which is apparent from Equation 19) and on problem setup.
More generally Sellke et al. (2001) give "calibrations"; e.g., their "simple calibration" is given as
leading to a fairly general lower bound,
for a valid postexperimental type I error rate, under a technical assumption, that the distribution of Ϫlog(p) under H 1 has a decreasing failure rate, which is shown to hold for a normal testing example with iid data. Unlike the problem-specific formula from Spiegelhalter and Smith, these bounds are not exact, and so we do not use them for experimental design. Making a decision on the basis of a P-value amounts to conditioning on (i.e., simplifying by replacing the data by) the event
occurring, where S is the sample space, i.e., conditioning on data we did not observe, which is an error (cf. Berger and Berry 1988). Strictly speaking we did not observe E p but
Similarly, making a decision on the basis of statistical significance for a predetermined value ␣ amounts to conditioning on
We can attempt to calculate a posterior probability for H 0 using only the information T Ն T ␣ , i.e., that the event E ␣ occurred. We have
by Bayes' rule, where Pr(H 0 ) is the prior probability that H 0 is true, and
Combining (B8) and (B9), setting 0 ϭ Pr(H 0 ) ϭ 1 Ϫ Pr(H 1 ), ␣ ϭ Pr(E ␣ |H 0 ), and solving gives
Note the dependence on Pr(E ␣ |H 1 ). To obtain small values for Pr(H 0 ) and hence good evidence for a real effect we need
which may not be the case, since the left-hand side of the inequality is not controlled solely by ␣. The left-hand side of (B11) is related to the power of the test. Specifically, let H 1 (d) represent the hypothesis ϭ d and (·) be the prior for in H 1 . Then
is the power function, giving the power to detect an effect of size d, at significance level ␣. Pr(E ␣ |H 1 ) can be represented as an integral of the power function,
giving the posterior probability of H 0 ,
A corresponding Bayes factor is given by
The left-hand side of (B14) is equivalent to the positive false discovery rate (Storey 2003; Equation B20 below) . Thus (B14) and (B15) show the relationship between the prior and posterior probabilities, a Bayes factor for rejected null hypotheses, type I error rates (␣), power curves, and positive false discovery rates. For the same reason that reporting ␣ is not fully efficient, using B ␣ (or the false discovery rate) instead of the Bayes factor or posterior probability based on the observed data (or T ϭ T obs ) is also not fully efficient as a summary of the observed data. Note that the integral in (B13), i.e., the Bayesian approach involving (d), is needed because d (the parameter being tested) is unknown. Since the power curve (B12) is monotonic, a non-Bayesian approximate upper bound for Pr(H 0 |E ␣ ) could be obtained if a lower bound, d l , for d was known. Suppose we had such a d l and d l Ͼ 0 (say); then
Of course we have no such bound a priori. A natural approach would be to let d l be the lower limit of a confidence interval (e.g., 95 or 99%) for d , so the bound holds to within a reasonably small error. The bound would not be useful unless the power P ␣ (d l ) was reasonably good, so we need d l to be at least 2 ( 
Thus we obtain, approximately, that Pr(
Note that this requires an estimated effect of twice the usual 2(d ) recommendation corresponding to P ϭ 0.05, to get a posterior probability of just Ͻ0.1. By comparison, if the assumptions for Sellke et al. (2001) , Equations B3 and B4, hold, the P-value corresponding to a valid postexperimental ␣ ϭ 0.05 or Pr(H 0 |E ␣ ) ϭ 0.05 is 0.0034, which corresponds to a 2.9(d )-sized effect. Problems with the interpretation of P-values as evidence have been pointed out in a number of articles (e.g., Edwards et al. 1963; Berger and Sellke 1987; Berger and Berry 1988) . Edwards et al. showed that the evidence corresponding to a given P-value was not as strong as most people think. The later work by Berger and co-authors shows that the problems with P-values, especially the common choice of P ϭ 0.05, are not specific to the choice of prior or to unusual examples but are quite general. For example, Berger and Berry consider the problem of testing for a biased coin. The example has P ϭ 0.05, yet the minimum value of Pr(H 0 ), assuming 0 ϭ 0.5 over a wide class of priors for the probability of heads, is 0.21. Results of this article show similar problems for common analysisof-variance models (Table 3) . For a long time these warnings have largely gone unheeded by the scientific community.
False discovery rates and q-values: Another alternative to p-values is the "false discovery rate" (FDR) (Benjamini and Hochberg 1995), which has become popular for handling multiple comparisons in genomics. Motivated by the low power obtained when using experimentwise error rates and many spurious significant results obtained when using comparisonwise error rates due to the large number of multiple comparisons being made in genome scans, with the false discovery rate one attempts to control the proportion of false positives among the rejected hypotheses. Storey (2003) considers a modification of the FDR, namely the positive false discovery rate (pFDR),
where V is the number of false positives (H 0 is true, but rejected) and R is the number of rejected null hypotheses (e.g., T Ͼ T ␣ ). The pFDR avoids a technical problem with V/R when R ϭ 0. This is shown to have a Bayesian interpretation, pFDR ϭ Pr(H 0 |T Ն T ␣ ).
Note that the right-hand side of (B20) is the same as (B14). The Bayes error (posterior probability or making a wrong decision for a given T ␣ ) is shown to be a combination of pFDR and the analogous positive false negative discovery rate (pFNR). Storey also defines the "q-value": analogous to the p-value being the lowest ␣ under which a hypothesis would be rejected, the q-value is the lowest pFDR consistent with the data. This optimistic choice (analogous to the definition of the p-value) means that the q-value has some if not all the limitations of the p-value-there is no valid interpretation of the q-value as an error rate (for false discoveries).
From a Bayesian perspective the use of false discovery rates is a step in the right direction-since using the frequentist FDR is approximately similar to using the Bayesian posterior probability. For example, the expected proportion of false positives among selected genes is simply the average posterior probability for the genes. These concepts are, however, superfluous within the Bayesian paradigm and we would not advocate using them unless for convenience, e.g., if they had already been calculated or the Bayesian model was difficult to fit. In the Bayesian paradigm there is no problem with multiple comparisons and no need to control the FDR-e.g., we compute posterior probabilities for each gene, giving the information needed to maximize expected utility directly. The FDR gives the properties of a procedure randomly, choosing a gene from a set of genes, corresponding to rejected null hypotheses, and ignoring the individual gene statistics, while the posterior probability gives the actual probability for each specific gene, which is clearly more informative.
Additionally, to estimate the FDR in the non-Bayesian framework, the prior probability for the proportion of true hypotheses needs to be estimated. This is where the procedure potentially loses efficiency compared to a full Bayesian model.
Rejecting or accepting H 0 is not the only option: Finally, we note that it is not always necessary to "reject" or "accept" H 0 , i.e., to choose only one of H 0 , H 1 and act as if the chosen model is the true model. As in Ball (2001), inference on genetic architecture and avoidance of selection bias in estimates of gene effects can be achieved by considering multiple models according to their posterior probabilities.
